{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:50:19Z","timestamp":1767423019185},"reference-count":59,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["AGL 2007-66308-C02-01\/GAN"],"award-info":[{"award-number":["AGL 2007-66308-C02-01\/GAN"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.091","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T09:43:41Z","timestamp":1252662221000},"page":"6695-6703","source":"Crossref","is-referenced-by-count":28,"title":["Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection"],"prefix":"10.1016","volume":"27","author":[{"given":"I.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Marcen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Abengozar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Larraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.091_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","volume":"57","author":"Alvar","year":"2004","journal-title":"Advances in Parasitology"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.091_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.091_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clinical Microbiology Reviews"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.08.091_bib5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"The Journal of Infectious Diseases"},{"issue":"February (7385)","key":"10.1016\/j.vaccine.2009.08.091_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"Davies","year":"2003","journal-title":"British Medical Journal (Clinical Research Edition)"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.091_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/3283159","article-title":"Canine leishmaniasis: pathological and ecological factors influencing transmission of infection","volume":"77","author":"Abranches","year":"1991","journal-title":"The Journal of Parasitology"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.091_bib8","first-page":"845","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nature Reviews"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2009.08.091_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0769-2625(87)80030-2","article-title":"Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets","volume":"138","author":"Locksley","year":"1987","journal-title":"Annales de l\u2019Institut Pasteur"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.08.091_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"The Journal of Experimental Medicine"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2009.08.091_bib11","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis","volume":"88","author":"Heinzel","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2009.08.091_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1989.tb00554.x","article-title":"Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major","volume":"112","author":"Muller","year":"1989","journal-title":"Immunological Reviews"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.091_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.091_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1354\/vp.42-2-166","article-title":"Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response","volume":"42","author":"Brachelente","year":"2005","journal-title":"Veterinary Pathology"},{"issue":"January (1\u20132)","key":"10.1016\/j.vaccine.2009.08.091_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.091_bib16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.091_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infection and Immunity"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.08.091_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/319869","article-title":"Tissue cytokine responses in canine visceral leishmaniasis","volume":"183","author":"Quinnell","year":"2001","journal-title":"The Journal of Infectious Diseases"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.08.091_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2009.08.091_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"The Journal of Experimental Medicine"},{"issue":"April (5210)","key":"10.1016\/j.vaccine.2009.08.091_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science (New York, NY)"},{"issue":"May (17\u201318)","key":"10.1016\/j.vaccine.2009.08.091_bib22","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0264-410X(02)00769-7","article-title":"DNA vaccines induce partial protection against Leishmania mexicana","volume":"21","author":"Dumonteil","year":"2003","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2009.08.091_bib23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2006.11.060","article-title":"Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice","volume":"25","author":"Gomes","year":"2007","journal-title":"Vaccine"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2009.08.091_bib24","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1432-1327.1999.00122.x","article-title":"Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36\/LACK protective antigen from Leishmania infantum","volume":"259","author":"Gonzalez-Aseguinolaza","year":"1999","journal-title":"European Journal of Biochemistry\/FEBS"},{"key":"10.1016\/j.vaccine.2009.08.091_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2859-4-26","article-title":"Ensuring safety of DNA vaccines","volume":"September (4)","author":"Glenting","year":"2005","journal-title":"Microbial Cell Factories"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.08.091_bib27","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1093\/nar\/29.5.e26","article-title":"Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration","volume":"29","author":"Cranenburgh","year":"2001","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.091_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/biot.200700141","article-title":"A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy","volume":"3","author":"Mairhofer","year":"2008","journal-title":"Biotechnology Journal"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.091_bib29","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infection and Immunity"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2009.08.091_bib30","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis","volume":"8","author":"Perez-Jimenez","year":"2006","journal-title":"Microbes and Infection\/Institut Pasteur"},{"issue":"April (3\u20134)","key":"10.1016\/j.vaccine.2009.08.091_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetpar.2006.01.011","article-title":"Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis","volume":"137","author":"Francino","year":"2006","journal-title":"Veterinary Parasitology"},{"issue":"August (34)","key":"10.1016\/j.vaccine.2009.08.091_bib33","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/j.vaccine.2008.06.006","article-title":"A heterologous prime\/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge","volume":"26","author":"Pretorius","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.091_bib34","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1371\/journal.pone.0001063","article-title":"Protection of rhesus monkeys by a DNA prime\/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens","volume":"2","author":"Weiss","year":"2007","journal-title":"PLoS ONE"},{"issue":"June (3\u20134)","key":"10.1016\/j.vaccine.2009.08.091_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vetimm.2008.02.004","article-title":"Associations among immunological, parasitological and clinical parameters in canine visceral leishmaniasis: Emaciation, spleen parasitism, specific antibodies and leishmanin skin test reaction","volume":"123","author":"Dos-Santos","year":"2008","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.091_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2427(95)05434-8","article-title":"Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis","volume":"48","author":"Martinez-Moreno","year":"1995","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"August (3\u20134)","key":"10.1016\/j.vaccine.2009.08.091_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2009.08.091_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(93)90295-I","article-title":"The separation and identification by monoclonal antibodies of dog IgG fractions","volume":"161","author":"Mazza","year":"1993","journal-title":"Journal of Immunological Methods"},{"issue":"June (1\u20132)","key":"10.1016\/j.vaccine.2009.08.091_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetpar.2007.03.037","article-title":"Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation","volume":"147","author":"Day","year":"2007","journal-title":"Veterinary Parasitology"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2009.08.091_bib40","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis","volume":"21","author":"de Oliveira Mendes","year":"2003","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.08.091_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2427(98)00213-X","article-title":"Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis","volume":"67","author":"Nieto","year":"1999","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.091_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Veterinary Parasitology"},{"issue":"May (1\u20132)","key":"10.1016\/j.vaccine.2009.08.091_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetimm.2007.01.014","article-title":"Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs","volume":"117","author":"Cardoso","year":"2007","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"May (3\u20134)","key":"10.1016\/j.vaccine.2009.08.091_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-2427(01)00270-7","article-title":"Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis","volume":"79","author":"Leandro","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"October (46)","key":"10.1016\/j.vaccine.2009.08.091_bib45","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"issue":"May (28)","key":"10.1016\/j.vaccine.2009.08.091_bib46","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.08.091_bib47","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.091_bib48","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1128\/IAI.71.6.3172-3182.2003","article-title":"Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection","volume":"71","author":"Colmenares","year":"2003","journal-title":"Infection and Immunity"},{"issue":"November\u2013December (11\u201312)","key":"10.1016\/j.vaccine.2009.08.091_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0141-9838.2004.00668.x","article-title":"Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells","volume":"25","author":"Herath","year":"2003","journal-title":"Parasite Immunology"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.08.091_bib50","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.147.5.1653","article-title":"Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines","volume":"147","author":"Holaday","year":"1991","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/expr.1999.4452","article-title":"Leishmania: naive human T cells sensitized with promastigote antigen and IL-12 develop into potent Th1 and CD8(+) cytotoxic effectors","volume":"93","author":"Russo","year":"1999","journal-title":"Experimental Parasitology"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.08.091_bib52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.174.3.499","article-title":"The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages","volume":"174","author":"Smith","year":"1991","journal-title":"The Journal of Experimental Medicine"},{"issue":"April (22)","key":"10.1016\/j.vaccine.2009.08.091_bib53","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0147-9571(00)00026-6","article-title":"Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes","volume":"24","author":"Panaro","year":"2001","journal-title":"Comparative Immunology, Microbiology and Infectious Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.091_bib55","first-page":"133","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nature Reviews"},{"issue":"5","key":"10.1016\/j.vaccine.2009.08.091_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","article-title":"IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins","volume":"24","author":"Hu","year":"2006","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.vaccine.2009.08.091_bib57","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.091_bib58","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/eji.200737660","article-title":"Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania","volume":"38","author":"Dondji","year":"2008","journal-title":"European Journal of Immunology"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2009.08.091_bib59","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0264-410X(01)00427-3","article-title":"A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36\/LACK antigen protects BALB\/c mice from cutaneous leishmaniasis","volume":"20","author":"Gonzalo","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:29:35Z","timestamp":1685125775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":59,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013000"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}